tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ironwood Pharma Receives Nasdaq Deficiency Letter
PremiumCompany AnnouncementsIronwood Pharma Receives Nasdaq Deficiency Letter
4M ago
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
Ironwood Pharmaceuticals Reports Q1 2025 Financial Results
5M ago
Ironwood reports Q1 EPS (14c), two estimates (3c)
Premium
The Fly
Ironwood reports Q1 EPS (14c), two estimates (3c)
5M ago
Ironwood downgraded to Hold from Buy at Craig-Hallum
PremiumThe FlyIronwood downgraded to Hold from Buy at Craig-Hallum
6M ago
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
Premium
Ratings
Ironwood Pharma: Hold Rating Amid Uncertainty Over Apraglutide’s Phase 3 Trial and Strategic Options
6M ago
Ironwood downgraded to Hold from Buy at Jefferies
Premium
The Fly
Ironwood downgraded to Hold from Buy at Jefferies
6M ago
Citizens JMP downgrades Ironwood on delayed apraglutide launch
PremiumThe FlyCitizens JMP downgrades Ironwood on delayed apraglutide launch
6M ago
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Ironwood downgraded to Market Perform from Outperform at Citizens JMP
6M ago
Morning Movers: Goldman Sachs gains following first quarter results
Premium
The Fly
Morning Movers: Goldman Sachs gains following first quarter results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100